PRE vs. CPIX
PRE (Prenetics Global Ltd) and CPIX (Cumberland Pharmaceuticals Inc.) are both stocks. Both are in the Healthcare sector — PRE in Diagnostics & Research, CPIX in Drug Manufacturers - Specialty & Generic. Over the past 3 years, PRE returned 21.67%/yr vs 66.39%/yr for CPIX. Their 0.05 correlation means their historical movements had little consistent relationship.
Performance
PRE vs. CPIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRE achieves a 18.35% return, which is significantly lower than CPIX's 67.84% return.
PRE
- 1D
- -3.12%
- 1M
- 10.10%
- 6M
- -2.38%
- YTD
- 18.35%
- 1Y
- 133.00%
- 3Y*
- 21.67%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -36.54%
CPIX
- 1D
- -0.74%
- 1M
- 4.87%
- 6M
- 78.13%
- YTD
- 67.84%
- 1Y
- 89.77%
- 3Y*
- 66.39%
- 5Y*
- 15.50%
- 10Y*
- 3.85%
- ALL TIME*
- -5.36%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $942.95K | $842.80K | $677.16K | |
| $3.85M | $4.87M | $4.52M |
PRE vs. CPIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
PRE Prenetics Global Ltd | 18.35% | 171.55% | -1.86% | -80.30% | -76.19% |
CPIX Cumberland Pharmaceuticals Inc. | 67.84% | 67.93% | 32.28% | -20.37% | -1.32% |
Correlation
The correlation between PRE and CPIX is 0.17, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.17 |
Correlation (3Y) Balances recent behavior with more history. | 0.08 |
Correlation (All Time) Calculated using the full available price history since May 18, 2022 | 0.05 |
The correlation between PRE and CPIX shifts across timeframes, from 0.05 (all time) to 0.17 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
PRE:
$316.89M
CPIX:
$100.09M
PRE:
-$4.54
CPIX:
-$0.49
PRE:
2.56
CPIX:
2.38
PRE:
2.61
CPIX:
4.62
PRE:
$113.75M
CPIX:
$41.94M
PRE:
$66.34M
CPIX:
$34.76M
PRE:
-$55.46M
CPIX:
-$3.18M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRE vs. CPIX — Risk / Return Rank
PRE
CPIX
PRE vs. CPIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Prenetics Global Ltd (PRE) and Cumberland Pharmaceuticals Inc. (CPIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PRE | CPIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.41 | ||
| Sortino ratioReturn per unit of downside risk | +0.31 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.24 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 3.83 | 1.79 | +2.05 |
| Martin ratioReturn relative to average drawdown | 8.67 | 3.71 | +4.96 |
Loading charts...
Drawdowns
PRE vs. CPIX - Drawdown Comparison
The maximum PRE drawdown since its inception was -97.70%, roughly equal to the maximum CPIX drawdown of -93.78%. Use the drawdown chart below to compare losses from any high point for PRE and CPIX.
Loading charts...
Drawdown Indicators
| PRE | CPIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.70% | -93.78% | -3.92% |
Max Drawdown (1Y)Largest decline over 1 year | -34.36% | -52.62% | +18.26% |
Max Drawdown (3Y)Largest decline over 3 years | -72.73% | -71.94% | -0.79% |
Max Drawdown (5Y)Largest decline over 5 years | — | -84.73% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -86.68% | — |
Current DrawdownCurrent decline from peak | -85.21% | -60.81% | -24.40% |
Average DrawdownAverage peak-to-trough decline | -86.78% | -70.69% | -16.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.19% | 25.34% | -10.15% |
Volatility
PRE vs. CPIX - Volatility Comparison
Prenetics Global Ltd (PRE) and Cumberland Pharmaceuticals Inc. (CPIX) have volatilities of 29.19% and 29.50%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRE | CPIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.19% | 29.50% | -0.31% |
Volatility (6M)Calculated over the trailing 6-month period | 61.04% | 60.76% | +0.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 89.43% | 88.18% | +1.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 88.68% | 115.14% | -26.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 88.68% | 87.01% | +1.67% |
Dividends
PRE vs. CPIX - Dividend Comparison
Neither PRE nor CPIX has paid dividends to shareholders.
Financials
PRE vs. CPIX - Financials Comparison
This section allows you to compare key financial metrics between Prenetics Global Ltd and Cumberland Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
PRE vs. CPIX - Profitability Comparison
PRE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Prenetics Global Ltd reported a gross profit of 23.28M and revenue of 35.95M. Therefore, the gross margin over that period was 64.8%.
CPIX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Cumberland Pharmaceuticals Inc. reported a gross profit of 7.20M and revenue of 9.13M. Therefore, the gross margin over that period was 78.8%.
PRE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Prenetics Global Ltd reported an operating income of -9.71M and revenue of 35.95M, resulting in an operating margin of -27.0%.
CPIX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Cumberland Pharmaceuticals Inc. reported an operating income of -3.13M and revenue of 9.13M, resulting in an operating margin of -34.3%.
PRE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Prenetics Global Ltd reported a net income of -23.10M and revenue of 35.95M, resulting in a net margin of -64.3%.
CPIX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Cumberland Pharmaceuticals Inc. reported a net income of -3.29M and revenue of 9.13M, resulting in a net margin of -36.0%.
Frequently Asked Questions
PRE and CPIX have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CPIX has higher volatility (29.50%) compared to PRE (29.19%). In terms of maximum drawdown, PRE dropped -97.70% vs CPIX's -93.78%.
PRE currently has the higher Sharpe Ratio (1.47 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRE and CPIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer